Rare diseases
Investigational molecules
Locations
40 Avenue De Verdun, 94000 Creteil, France
Centre Hospitalier Intercommunal Creteil in Creteil, France specialises in clinical trials of conditions such as Non-small cell lung cancer, Non-small cell lung cancer stage IV, Asthma, Non-small cell lung cancer metastatic, and other specialisations. This site conducts important research.
At Centre Hospitalier Intercommunal Creteil, clinical trial activity is focused on cancer research, with a strong emphasis on treatments for extensive stage small cell lung cancer. The studies are designed to evaluate whether new treatment approaches can improve patient outcomes and extend survival in this difficult-to-treat disease.
This medical oncology program reflects a targeted effort to advance care for aggressive neoplasms through studies that compare new therapeutic strategies with current standard treatment.
Clinical trials currently enrolling participants at this site.
Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
FranceStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
FranceStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
FranceStudy on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer
FranceStudy on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors
FranceA study of MK-1084 and pembrolizumab for patients with resected KRAS G12C-mutant non-small cell lung cancer
FranceStudy of Beclometasone Dipropionate in Patients with Asthma to Evaluate Disease Characteristics and Control
FranceLong‑term Safety of Adagrasib with Drug Combination in Adults with Solid Tumors
FranceA Study of ABBV-706 to Assess Safety and Efficacy Compared with Standard Drug Combination in Adults with Relapsed or Refractory Small Cell Lung Cancer
FranceSafety, Pharmacokinetics, and Exploratory Efficacy of BI 1015550 and Nerandomilast in Children and Adolescents Aged 2‑17 Years With Fibrosing Interstitial Lung Disease
FranceStudy of MK-1084 plus durvalumab versus placebo plus durvalumab in patients with locally advanced KRAS G12C‑mutant non‑small cell lung cancer after chemoradiotherapy
FranceA Phase 2/3 Study of intravitreal mk-8748 versus aflibercept in adults with neovascular age‑related macular degeneration
FranceMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
